Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-27T00:40:35.275Z Has data issue: false hasContentIssue false
  • English
  • Français

Audit and Feedback to Reduce Broad-Spectrum Antibiotic Use among Intensive Care Unit Patients A Controlled Interrupted Time Series Analysis

Published online by Cambridge University Press:  02 January 2015

Marion Elligsen ,
Sandra A. N. Walker ,
Ruxandra Pinto ,
Andrew Simor ,
Samira Mubareka ,
Anita Rachlis ,
Vanessa Allen  and
Nick Daneman
Marion Elligsen
Affiliation:
Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Sandra A. N. Walker
Affiliation:
Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Leslie L. Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada Department of Microbiology and Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Ruxandra Pinto
Affiliation:
Sunnybrook Research Institute, Toronto, Ontario, Canada
Andrew Simor
Affiliation:
Department of Microbiology and Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Samira Mubareka
Affiliation:
Sunnybrook Research Institute, Toronto, Ontario, Canada Department of Microbiology and Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Anita Rachlis
Affiliation:
Department of Microbiology and Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Vanessa Allen
Affiliation:
Department of Microbiology and Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada Public Health Ontario, Toronto, Ontario, Canada
Nick Daneman*
Affiliation:
Sunnybrook Research Institute, Toronto, Ontario, Canada Department of Microbiology and Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
*
Division of Infectious Diseases, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 2M5, Canada ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

We aimed to rigorously evaluate the impact of prospective audit and feedback on broad-spectrum antimicrobial use among critical care patients.

Design.

Prospective, controlled interrupted time series.

Setting

Single tertiary care center with 3 intensive care units.

Patients and Interventions.

A formal review of all critical care patients on their third or tenth day of broad-spectrum antibiotic therapy was conducted, and suggestions for antimicrobial optimization were communicated to the critical care team.

Outcomes.

The primary outcome was broad-spectrum antibiotic use (days of therapy per 1000 patient-days; secondary outcomes included overall antibiotic use, gram-negative bacterial susceptibility, nosocomial Clostridium difficile infections, length of stay, and mortality.

Results.

The mean monthly broad-spectrum antibiotic use decreased from 644 days of therapy per 1,000 patient-days in the preintervention period to 503 days of therapy per 1,000 patient-days in the postintervention period (P < .0001); time series modeling confirmed an immediate decrease (± standard error) of 119 ± 37.9 days of therapy per 1,000 patient-days (P = .0054). In contrast, no changes were identified in the use of broad-spectrum antibiotics in the control group (nonintervention medical and surgical wards) or in the use of control medications in critical care (stress ulcer prophylaxis). The incidence of nosocomial C. difficile infections decreased from 11 to 6 cases in the study intensive care units, whereas the incidence increased from 87 to 116 cases in the control wards (P = .04). Overall gram-negative susceptibility to meropenem increased in the critical care units. Intensive care unit length of stay and mortality did not change.

Conclusions.

Institution of a formal prospective audit and feedback program appears to be a safe and effective means to improve broad-spectrum antimicrobial use in critical care.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 33 , Issue 4: Special Topic Issue: Antimicrobial Stewardship , April 2012 , pp. 354 - 361
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Pakyz, AL, MacDougall, C, Oinonen, M, Polk, RE. Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch Intern Med 2008;168:2254–2260.CrossRefGoogle ScholarPubMed
2. Ansari, F, Erntell, M, Goossens, H, Davey, P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 2009;49:1496–1504.CrossRefGoogle ScholarPubMed
3. Hecker, MT, Aron, DC, Patel, NP, Lehmann, MK, Donskey, CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003;163:972–978.CrossRefGoogle ScholarPubMed
4. Dellit, TH, Owens, RC, McGowan, JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.CrossRefGoogle Scholar
5. Gould, LM. Minimum antibiotic stewardship measures. Clin Microbiol 2001;7(suppl 6):22–26.CrossRefGoogle ScholarPubMed
6. Lawrence, KL, Kollef, MH. Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med 2009;179:434–438.CrossRefGoogle ScholarPubMed
7. Brown, EM, Nathwani, D. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Anrimicrob Chemother 2005;55:6–9.CrossRefGoogle ScholarPubMed
8. Vincent, JL, Relio, J, Marshall, J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323–2329.CrossRefGoogle Scholar
9. Kaki, R, Elligsen, M, Walker, S, Simor, A, Palmay, L, Daneman, N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 2011;66:1223–1230.CrossRefGoogle ScholarPubMed
10. Fan, E, Laupacis, A, Pronovost, PJ, Guyatt, GH, Needham, DM. How to use an article about quality improvement. JAMA 2010; 304:2279–2287.CrossRefGoogle ScholarPubMed
11. Polk, RE, Fox, C, Mahoney, A, Letcavage, J, MacDougall, C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44:664–670.CrossRefGoogle ScholarPubMed
12. Anderson, DJ, Kaye, KS, Classen, D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S51–S61.CrossRefGoogle ScholarPubMed
13. Hussey, MA, Hughes, JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 2007;28:182–191.CrossRefGoogle ScholarPubMed
14. Gibbs, L, Kakis, A, Weinstein, P, Conte, JE Jr. Bone wax as a risk factor for surgical-site infection following neurospinal surgery. Infect Control Hosp Epidemiol 2004;25:346–348.CrossRefGoogle ScholarPubMed
15. Geissler, A, Gerbeaux, P, Granier, I, Blanc, P, Facon, K, Durand-Gasselin, J. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med 2003;29:49–54.CrossRefGoogle ScholarPubMed
16. Marra, AR, de Almeida, SM, Correa, L, et al. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control 2009;37:204–209.CrossRefGoogle ScholarPubMed
17. Brahmi, N, Biel, Y, Kouraichi, N, Ben, HR, Thabet, H, Amamou, M. Impact of antibiotic use and prescribing policy in a Tunisian intensive care unit [in French]. Med Mai Infect 2006;36:460–465.CrossRefGoogle Scholar
18. Starr, JM, Campbell, A, Renshaw, E, Poxton, IR, Gibson, GJ. Spatio-temporal stochastic modelling of Clostridium difficile . J Hosp Infect 2009;71:49–56.CrossRefGoogle ScholarPubMed
19. Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007; 45(suppl 2):S112–S121.CrossRefGoogle ScholarPubMed
20. Ntagiopoulos, PG, Paramythiotou, E, Antoniadou, A, Giamarellou, H, Karabinis, A. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of gram-negative microorganisms in an intensive care unit in Greece. Int J Antimicrob Agents 2007; 30:360–365.CrossRefGoogle Scholar
21. Brahmi, N, Biel, Y, Kouraichi, N, et al. Impact of ceftazidime restriction on gram-negative bacterial resistance in an intensive care unit. J Infect Chemother 2006;12:190–194.CrossRefGoogle Scholar
22. Elligsen, M, Walker, S, Simor, A, Daneman, N. Antimicrobial prospective-audit and feedback in critical care: program implementation, experience and challenges. Can J Hosp Pharm (forthcoming).Google Scholar